V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20220796 | 20178481 | 1.63 | 66 | Palliative (P) | 2018-08-08 | 2018-08-17 | Panitumumab | 2 | N | PANITUMUMAB | 100424166 |
| 20220800 | 20178482 | 1.9 | 45 | Palliative (P) | 2020-05-04 | 2020-05-09 | null | 02 | N | PANITUMUMAB | 100941969 |
| 20220833 | 20178483 | 1.71 | null | Adjuvant (A) | 2021-03-17 | 2021-04-25 | null | 02 | Y | CISPLATIN + FLUOROURACIL | 101740835 |
| 20220846 | 20178484 | 1.82 | 98.6 | Curative (C) | null | 2018-12-15 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100709450 |
| 20220864 | 20178485 | null | 45.2 | Palliative (P) | 2018-12-21 | 2018-12-22 | null | 02 | N | ECX | 100086352 |
| 20220996 | 20178487 | 1.66 | 87.25 | Palliative (P) | 2017-05-18 | 2017-05-30 | Panitumumab | 02 | N | PANITUMUMAB | 101819144 |
| 20221057 | 20178488 | null | null | Palliative (P) | 2020-04-25 | 2020-04-25 | null | 02 | N | PANITUMUMAB | 100264853 |
| 20221079 | 20178489 | 1.72 | 43.5 | Palliative (P) | 2021-06-12 | 2021-06-28 | Carboplatin + Etoposide IV 3 day | 02 | N | CARBOPLATIN + ETOPOSIDE | 101699760 |
| 20221103 | 20178490 | 1.71 | 68.7 | Palliative (P) | 2016-07-24 | 2016-07-24 | null | 02 | N | NIVOLUMAB | 101482232 |
| 20221104 | 20178491 | null | 71.35 | Neo-adjuvant (N) | 2017-05-14 | 2017-06-11 | NIVOLUMAB | 02 | N | NIVOLUMAB | 100266547 |
| 20221118 | 20178492 | 1.54 | 60.5 | null | 2017-03-18 | 2017-03-26 | null | 02 | null | NIVOLUMAB | 100595490 |
| 20221185 | 20178493 | 1.61 | 57 | Palliative (P) | 2016-10-02 | 2017-04-20 | null | 02 | N | CARBOPLATIN + ETOPOSIDE | 101382602 |
| 20221297 | 20178494 | 1.78 | 60 | Adjuvant (A) | 2018-03-26 | 2018-04-04 | Carboplatin + Etoposide iv&po | N | null | CARBOPLATIN + ETOPOSIDE | 100123939 |
| 20221300 | 20178495 | 1.72 | 66.9 | Neo-adjuvant (N) | 2019-07-14 | 2019-07-28 | Cisplatin +Fluorouracil (3 wk) | 02 | n | CISPLATIN + FLUOROURACIL | 101375907 |
| 20221413 | 20178496 | 1.84 | 72 | Palliative (P) | 2018-01-24 | 2018-09-24 | null | 02 | N | CARBOPLATIN + ETOPOSIDE | 100575563 |
| 20221450 | 20178497 | 1.86 | 67.3 | Palliative (P) | 2018-08-20 | 2018-08-26 | null | N | N | CARBOPLATIN + ETOPOSIDE | 101030491 |
| 20221483 | 20178498 | 1.64 | 58.05 | Adjuvant (A) | 2020-10-08 | 2020-10-08 | null | 02 | Y | CISPLATIN + FLUOROURACIL | 100896888 |
| 20221496 | 20178499 | 1.85 | 75.6 | null | null | 2016-12-21 | NIVOLUMAB | 02 | Y | NIVOLUMAB | 100410223 |
| 20221713 | 20178501 | 1.8 | null | null | null | 2018-10-20 | Panitumumab | N | null | PANITUMUMAB | 100830799 |
| 20221872 | 20178503 | null | null | null | 2018-06-17 | 2018-06-17 | Cisplatin +Fluorouracil (3 wk) | 02 | null | CISPLATIN + FLUOROURACIL | 101483998 |
| 20221892 | 20178504 | 1.81 | 84 | Palliative (P) | 2017-07-01 | 2017-07-03 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 100661654 |
| 20221947 | 20178506 | 1.61 | 97.7 | null | 2014-12-01 | 2014-12-08 | CISPLATIN + FLUOROURACIL + RT | 02 | null | CISPLATIN + FLUOROURACIL | 100612789 |
| 20221977 | 20178507 | null | null | Palliative (P) | 2016-09-13 | 2016-09-16 | null | 02 | N | PANITUMUMAB | 100127787 |
| 20222025 | 20178508 | 1.73 | 87.6 | null | 2020-02-28 | 2020-03-21 | null | 02 | null | ECX | 100851418 |
| 20222048 | 20178509 | 1.56 | 72.8 | null | 2019-10-30 | 2019-11-04 | null | 02 | null | CARBOPLATIN + ETOPOSIDE | 101251843 |
| 20222145 | 20178510 | 1.6 | 75.6 | null | 2016-08-14 | 2016-09-20 | NIVOLUMAB | null | N | NIVOLUMAB | 101584749 |
| 20222190 | 20178511 | 1.64 | 86.5 | Palliative (P) | 2018-03-15 | 2018-05-04 | Panitumumab | 02 | N | PANITUMUMAB | 100482105 |
| 20222368 | 20178512 | 1.8 | null | null | 2016-10-11 | 2016-10-13 | null | 02 | null | PANITUMUMAB | 100319905 |
| 20222448 | 20178514 | null | 55.3 | Neo-adjuvant (N) | 2019-09-18 | 2019-09-18 | ECX | N | N | ECX | 101824579 |
| 20222603 | 20178515 | 1.58 | null | null | 2017-03-08 | 2017-03-23 | Cisplatin +Fluorouracil (3 wk) | 02 | null | CISPLATIN + FLUOROURACIL | 101233359 |
| 20222626 | 20178516 | 1.54 | 81.9 | null | 2019-03-14 | 2019-03-22 | ECX | N | null | ECX | 101022540 |
| 20222799 | 20178517 | 1.86 | 73.6 | null | 2020-01-13 | 2020-01-13 | null | 02 | N | CARBOPLATIN + ETOPOSIDE | 100053931 |
| 20222811 | 20178518 | null | null | null | null | 2017-02-13 | Panitumumab | 02 | N | PANITUMUMAB | 101581646 |
| 20222830 | 20178519 | 1.79 | 86 | null | 2018-02-02 | 2018-07-11 | null | 02 | null | NIVOLUMAB | 101294353 |
| 20222858 | 20178520 | 1.63 | 118.3 | null | 2018-07-22 | 2018-09-16 | CISPLATIN + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 101200002 |
| 20222906 | 20178521 | 1.73 | 88 | null | 2018-05-30 | 2018-06-07 | CISPLATIN + FLUOROURACIL | 02 | N | CISPLATIN + FLUOROURACIL | 101095083 |
| 20222951 | 20178522 | null | 101 | Curative (C) | 2020-02-14 | 2020-02-15 | null | 02 | N | CISPLATIN + FLUOROURACIL | 101348673 |
| 20223054 | 20178523 | 1.84 | 88.5 | Adjuvant (A) | 2018-09-07 | 2019-11-28 | Panitumumab | N | Y | PANITUMUMAB | 100490988 |
| 20223108 | 20178524 | 1.76 | 82.3 | null | 2015-11-08 | 2016-07-03 | CARBOPLATIN + ETOPOSIDE | 02 | null | CARBOPLATIN + ETOPOSIDE | 101779787 |
| 20223193 | 20178525 | null | 62.1 | null | null | 2019-08-30 | null | 02 | null | CISPLATIN + FLUOROURACIL | 101448378 |
| 20223272 | 20178526 | 1.89 | 68.2 | null | 2017-09-19 | 2017-09-21 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100588758 |
| 20223359 | 20178527 | 1.61 | 59.1 | null | 2021-11-26 | 2021-12-12 | Cisplatin + Fluorouracil + RT 5day | N | N | CISPLATIN + FLUOROURACIL | 101719266 |
| 20223412 | 20178528 | 1.75 | 85.5 | Palliative (P) | 2016-11-03 | 2016-11-30 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 101451890 |
| 20223430 | 20178529 | 1.8 | 96 | Curative (C) | 2017-04-06 | 2018-02-21 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 2 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101818952 |
| 20223463 | 20178530 | 1.67 | 53.6 | Palliative (P) | 2017-07-14 | 2017-07-24 | EOX | 02 | N | OXALIPLATIN + RALTITREXED | 100218749 |
| 20223478 | 20178531 | 1.78 | 69.6 | Palliative (P) | 2016-09-04 | 2016-09-20 | CETUXIMAB + IRINOTECAN + MDG | 01 | N | CETUXIMAB + IRINOTECAN + MDG | 101139357 |
| 20223545 | 20178532 | 1.63 | 72 | Palliative (P) | 2017-06-11 | 2017-06-15 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 101021219 |
| 20223655 | 20178533 | 1.84 | 48 | null | 2016-02-09 | 2016-11-04 | EOX | 2 | null | EOX | 101835774 |
| 20223741 | 20178534 | 1.89 | 66.2 | null | 2016-08-28 | 2016-11-06 | IRINOTECAN + MDG + PANITUMUMAB | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100284227 |
| 20223848 | 20178535 | 1.77 | 46.9 | null | 2018-01-16 | 2018-02-10 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100540643 |